Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 3/20 | 0.50 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.49 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.49 |
| ▸ | HINT1 | P49773 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8529895 | 0.93 | P2RY11 (0.54) | SLC29A1P2RY11CYP2C19ADORA2AADORA2B | |
| SCHEMBL17359509 | 0.85 | P2RX3 (0.49) | SLC29A1P2RY11CYP2C19ADORA2AADORA2B | |
| SCHEMBL8529892 | 0.85 | CYP2C19 (0.52) | SLC29A1CYP2C19ADORA2AADORA2BADORA3 | |
| SCHEMBL17357579 | 0.82 | P2RY11 (0.46) | SLC29A1P2RY11CYP2C19ADORA2AADORA2B | |
| SCHEMBL29479248 | 0.82 | HINT1 (0.59) | P2RY11ENPP1HINT1 | |
| Nelarabine SCHEMBL14031852 | 0.81 | CYP2C19 (0.71) | SLC29A1CYP2C19ADORA2AADORA2BADORA3 | |
| Nelarabine SCHEMBL18321891 | 0.81 | CYP2C19 (0.71) | SLC29A1CYP2C19ADORA2AADORA2BADORA3 | |
| Nelarabine SCHEMBL2143756 | 0.81 | CYP2C19 (0.71) | SLC29A1CYP2C19ADORA2AADORA2BADORA3 | |
| Nelarabine SCHEMBL20769831 | 0.81 | CYP2C19 (0.71) | SLC29A1CYP2C19ADORA2AADORA2BADORA3 | |
| Nelarabine SCHEMBL13657986 | 0.81 | CYP2C19 (0.71) | SLC29A1CYP2C19ADORA2AADORA2BADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5821236-A | Tumor treatment with arabinofuranosyl purine derivatives | GLAXO WELLCOME INC. (US) | 1998-10-13 | — | — | US | disclosed |
| US-5747472-A | ANTICARCINOGENIC AGENTS AND ANTITUMOR AGENTS | GLAXO WELLCOME INC. (US) | 1998-05-05 | — | — | US | disclosed |
| US-5492897-A | ANTITUMOR AGENTS, AUTOIMMUNE DISEASES | BURROUGHS WELLCOME CO. (141) (US) | 1996-02-20 | — | — | US | disclosed |
| US-5424295-A | Useful in treatment of varicella-zoster virus infections | BURROUGHS WELLCOME CO. (US) | 1995-06-13 | — | — | US | disclosed |